Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
Doreen Ndovie
2 min
Knowledge
Description
<p>Dr. Rae Bacharach discusses the paper, "Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis".</p> <p>Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2806000</p>
Uploader
scooter_wave
Episodes
1
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
Doreen Ndovie